CHILDRENS MEDICINES
March 1st, 2003
BY KEITH NUTHALLTHE EUROPEAN Agency for the Evaluation of Medicinal Products has released a detailed paper proposing that guidelines are drawn up for the development and application of medicines designed for use by children. It has suggested that a Paediatric Pharmacovigilance Guideline is written by the European Union's (EU) CPMP Pharmacovigilance Working Party, "to underpin" other strategies currently being considered by EU regulators. Issues that should be covered by the guidelines, said the paper, include data collection and management, the detection of ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.